FDA Seeks Input on Gluten in Drugs to Protect Celiac Disease Patients

In 2011, the FDA opened a docket for discussing gluten-free food labeling to help those wth celiac disease and high gluten intolerance. This year’s subject open for discussion is gluten in drugs. The products in question include prescription, nonprescription, biologic, and homeopathic drugs. Learn about the FDA’s assessment results on the percentage of gluten tolerated by those with celiac disease and what they are seeking in regards to comments on gluten in medication and from whom. Continue reading “FDA Seeks Input on Gluten in Drugs to Protect Celiac Disease Patients”